PRTA - Prothena Corporation plc

NasdaqGS - NasdaqGS Delayed Price. Currency in USD

Prothena Corporation plc

Adelphi Plaza
Upper George's Street
D??n Laoghaire A96 T927
353 1 236 2500

Full Time Employees96

Key Executives

Mr. Gene G. Kinney Ph.D.Pres, CEO & Director645.61k1.43M48
Mr. Tran B. Nguyen M.B.A.Chief Financial Officer532.64kN/A43
Mr. Arthur W. Homan J.D.Chief Legal Officer492.24k614.19k58
Ms. Carol D. KarpChief Regulatory Officer324.49kN/A64
Ms. Karin L. Walker CPAChief Accounting Officer & ControllerN/AN/A54
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on the discovery, development, and commercialization of novel immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion. It is developing antibody-based product candidates that include NEOD001, a monoclonal antibody that is in Phase III and Phase IIb clinical trials for the treatment of AL amyloidosis; PRX002 that has completed Phase Ib clinical trial for treating Parkinson’s disease and other related synucleinopathies; PRX003, a monoclonal antibody that is in Phase Ib for the treatment of psoriasis and other inflammatory diseases; and PRX004, a monoclonal antibody that is under preclinical development. The company has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein. Prothena Corporation plc was incorporated in 2012 and is headquartered in Dún Laoghaire, Ireland.

Corporate Governance

Prothena Corporation plc’s ISS Governance QualityScore as of December 1, 2017 is 4. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 4; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.